1. Home
  2. CNTA vs ROOT Comparison

CNTA vs ROOT Comparison

Compare CNTA & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • ROOT
  • Stock Information
  • Founded
  • CNTA 2020
  • ROOT 2015
  • Country
  • CNTA United Kingdom
  • ROOT United States
  • Employees
  • CNTA N/A
  • ROOT N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • ROOT Property-Casualty Insurers
  • Sector
  • CNTA Health Care
  • ROOT Finance
  • Exchange
  • CNTA Nasdaq
  • ROOT Nasdaq
  • Market Cap
  • CNTA 2.3B
  • ROOT 2.3B
  • IPO Year
  • CNTA 2021
  • ROOT 2020
  • Fundamental
  • Price
  • CNTA $17.01
  • ROOT $91.01
  • Analyst Decision
  • CNTA Strong Buy
  • ROOT Buy
  • Analyst Count
  • CNTA 10
  • ROOT 6
  • Target Price
  • CNTA $30.56
  • ROOT $130.60
  • AVG Volume (30 Days)
  • CNTA 1.2M
  • ROOT 769.4K
  • Earning Date
  • CNTA 08-12-2025
  • ROOT 08-06-2025
  • Dividend Yield
  • CNTA N/A
  • ROOT N/A
  • EPS Growth
  • CNTA N/A
  • ROOT N/A
  • EPS
  • CNTA N/A
  • ROOT 4.73
  • Revenue
  • CNTA $15,000,000.00
  • ROOT $1,364,700,000.00
  • Revenue This Year
  • CNTA N/A
  • ROOT $23.08
  • Revenue Next Year
  • CNTA N/A
  • ROOT $11.12
  • P/E Ratio
  • CNTA N/A
  • ROOT $19.25
  • Revenue Growth
  • CNTA 118.88
  • ROOT 59.76
  • 52 Week Low
  • CNTA $9.60
  • ROOT $34.04
  • 52 Week High
  • CNTA $19.09
  • ROOT $181.14
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 54.91
  • ROOT 36.81
  • Support Level
  • CNTA $17.01
  • ROOT $83.77
  • Resistance Level
  • CNTA $18.14
  • ROOT $90.69
  • Average True Range (ATR)
  • CNTA 0.81
  • ROOT 7.07
  • MACD
  • CNTA -0.10
  • ROOT -0.33
  • Stochastic Oscillator
  • CNTA 51.08
  • ROOT 15.82

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.

Share on Social Networks: